Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion type Assertion NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_head.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion description "[Inhibitors of the PI3K pathway are in clinical testing in patients with solid tumors, including uterine cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion evidence source_evidence_literature NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion SIO_000772 21903247 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion wasDerivedFrom befree-20140225 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion wasGeneratedBy ECO_0000203 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.